Weight loss medications should be the first step to prevent heart disease, the top cardiology group says



According to the American Cardiology College, more American weight loss drugs should be taken to prevent heart disease.

The exercise and a clean diet is not enough for heart health, but the nation’s best cardiology organization said New tricks Released on Friday. For group patients, part of the first defense line should be used before.

Novo Nordisk A / SWegovy and Eli Lilly & Co.According to new instructions, zepbound must be taken into account when choosing initial treatment to prevent heart disease. Famous drugs are more effective than lifestyle changes and have less risks than surgery.

“We have heard that drugs have a great victory and such props,” Mizuho Securities “from Jared Holz to customers.

Nova’s shares of Nova’s listed in the United States were spread shortly after the release of new instructions, and then decreased by 11:22% in New York. Lilly, a decline before, reduced by 2.8%.

ACC’s recommendation is the separation of the previous advice from the lawyer for lifestyle changes before obesity medications. Patients should not “try and fail” before able to get strong drugs that prove their ability to lose weight and improve heart health. Olivia Gilberta cardiologist Atrium health Forest Baptist Medical Center, which leads to work in new instructions.

It is said that the change intends to affect insurance companies and federal programs that decided to cover the recipe medications. Cardiologists support more patients for medicines for more patients and medicines from Novo and Lilly, a wider insurance for medicines for a market control Morgan Stanley Analysts It is contrary to saying $ 150 billion in sales in the highest sales for a decade.

New instructions can sweep the results of public health and policy that can reduce heart disease loss, “and this is incredibly interesting,” Gilbert said.

According to Gilbert, people should be able to cancel the members of the gym “completely”. Medicines will help you lose weight and, “If there is something that needs to increase your physical activity,” he said. “Designed to work in Tandem.”

According to the centers of disease and prevention, more than 40% of adults in the United States are obese. Uncertainty about the insurance coverage is an important obstacle of treatment, he said that the ACC is “continued to improve this therapy.”

According to new instructions, the physical mass can determine whose treatment for the body mass index, weight and height or other risk factors, whose treatment for a calculation related to the heart and height or height.

The connection between obesity and heart health is not new, but patients must lose 10% of the body weight to reduce cardiovascular risks and 15% need to lose 15% to flush deaths. He said that drug therapy could be the best and most favorable way.

Many insurers do not cover existing drugs for consumers who cost $ 100,000 for a monthly supply without insurance, but for consumers who buy them directly with cash. According to Gilbert, the new ACT administration may affect the negotiations with private insurance companies and Medicare and Medicare and Medicaid, the U.S. government for the elderly and poor insurance programs. Most Medicare and Medicaid pay weight for diabetic patients, they are not currently covered for obesity.

In March last year, the Food and Drug Department confirmed to reduce the first of the heart attacks and heart disease and heart disease and heart disease, to reduce the first to prevent potential deadly heart problems. Although the agency still cleans the Lilly Zepbound to treat cardiovascular diseases, last year, the late stage decreased deaths from heart failure.

Lilly changed Lilly, saying that this is the importance of being treated early and effectively. Novo applauded the action of the ACC as “today’s treatment scene”.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *